MACE HR (95% CI) | p Value | Coronary revascularisation HR (95% CI) | p Value | |
---|---|---|---|---|
Smoker | 1.41 (0.29 to 6.92) | 0.67 | 1.31 (0.66 to 2.62) | 0.45 |
HT | 2.91 (0.35 to 24.70) | 0.33 | 1.91 (0.86 to 4.23) | 0.11 |
+FH | – | – | 0.81 (0.39 to 1.69) | 0.57 |
Cholesterol | 1.02 (0.66 to 1.40) | 0.94 | 1.26 (0.54 to 2.94) | 0.60 |
DM | 1.79 (0.29 to 11.17) | 0.54 | 1.46 (0.61 to 3.50) | 0.40 |
CCS | ||||
≥10 | 5.79 (0.70 to 47.59) | 0.10 | 5.05 (2.12 to 12.05) | <0.001 |
≥100 | 3.93 (0.89 to 17.42) | 0.08 | 6.01 (3.03 to 11.92) | <0.0001 |
≥400 | 5.57 (1.26 to 24.70) | <0.05* | 3.90 (1.99 to 7.65) | <0.0001 |
CT | ||||
<50% | 2.87 (0.69 to 11.93) | 0.15 | 0.25 (0.06 to 1.03) | 0.06 |
50–70% | – | – | 0.32 (0.04 to 2.32) | 0.26 |
>70% | 3.40 (0.85 to 13.51) | 0.08 | 27.92 (9.94 to 78.43) | <0.0001* |
SIS | ||||
≥1 | 1.33 (0.29 to 6.15) | p=0.72 | 3.65 (1.9 to 7.0) | p<0.0001* |
≥5 | 6.50 (1.19 to 16.02) | p<0.05* | 7.13 (2.2 to 23.1) | p<0.0001* |
ncSIS | ||||
≥1 | 1.27 (0.23 to 5.05) | p=0.74 | 2.36 (1.20 to 4.63) | p<0.01* |
≥5 | 5.75 (0.69 to 47.94) | p=0.11 | 1.82 (0.43 to 747) | p=0.42 |
*Statistical significance.
+FH, positive family history; CAD, coronary artery disease; CCS, coronary calcium score; DM, diabetes mellitus; HT, arterial hypertension; ncSIS, non-calcified plaque segment involvement score; SIS, segment involvement score (reflecting total plaque burden).